SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nghiem B. Ha, Nghi B. Ha, Kevin T. Chaung, Huy N. Trinh, Huy A. Nguyen, Khanh K. Nguyen, Mindie H. Nguyen, Similar Response to Entecavir 0.5 and 1.0 Mg in Treatment-Naïve Chronic Hepatitis B Patients: A Case-Control Study, Digestive Diseases and Sciences, 2014, 59, 1, 168

    CrossRef

  2. 2
    Jimi Yoon, Donghwa Park, Chiyeon Kim, A Granulomatous Drug Eruption Induced by Entecavir, Annals of Dermatology, 2013, 25, 4, 493

    CrossRef

  3. 3
    John A. Easter, Richard C. Burrell, Samuel J. Bonacorsi, An alternative and robust synthesis of [13C4]Baraclude® (entecavir), Journal of Labelled Compounds and Radiopharmaceuticals, 2013, 56, 12
  4. 4
    Yihu Zheng, Shengchu Zhang, Hooi Min Tan Grahn, Chao Ye, Zheng Gong, Qiyu Zhang, Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis, Hepatitis Monthly, 2013, 13, 4

    CrossRef

  5. 5
    Nghiem B. Ha, Nghi B. Ha, Huy N. Trinh, Huy A. Nguyen, Khanh K. Nguyen, Mindie H. Nguyen, Response to Higher Dose of Entecavir 1.0 mg Daily in Patients With Partial Response to Entecavir 0.5 mg Daily, Journal of Clinical Gastroenterology, 2013, 47, 5, 461

    CrossRef

  6. You have free access to this content6
    Geoffrey Dusheiko, Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues, Liver International, 2013, 33,
  7. 7
    Xiaoyu Liu, Xiaozhen Jiao, Qian Wu, Chengsen Tian, Renze Li, Ping Xie, A novel and efficient synthesis of Entecavir, Tetrahedron Letters, 2012, 53, 29, 3805

    CrossRef

  8. 8
    Natalie H. Bzowej, Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant, Current Hepatitis Reports, 2012, 11, 2, 82

    CrossRef

  9. 9
    Bing Zhou, Yuanchao Li, Synthesis of Entecavir (BMS-200475), Tetrahedron Letters, 2012, 53, 5, 502

    CrossRef

  10. 10
    Behzad Einollahi, Therapy for HBV Infection in Hemodialysis Patients: Is it Possible?, Hepatitis Monthly, 2012, 12, 3, 153

    CrossRef

  11. 11
    Ajay Kumar, Manisha Dwivedi, S. P. Misra, Sushil Narang, Balesh Kumar Tiwari, Renu Pandey, Clinical Profile, Genotype and Management Updates of Hepatitis B Virus, Indian Journal of Virology, 2011, 22, 1, 1

    CrossRef

  12. 12
    Hiroyuki Yoshitsugu, Takao Sakurai, Hiroki Ishikawa, Amit Roy, Marc Bifano, Marc Pfister, Taku Seriu, Masaki Hiraoka, Pooled model-based approach to compare the pharmacokinetics of entecavir between Japanese and non-Japanese chronic hepatitis B patients, Diagnostic Microbiology and Infectious Disease, 2011, 70, 1, 91

    CrossRef

  13. 13
    Richard Guan, Hock Foong Lui, Treatment of Hepatitis B in Decompensated Liver Cirrhosis, International Journal of Hepatology, 2011, 2011, 1

    CrossRef

  14. 14
    Natalie H. Bzowej, Hepatitis B Therapy in Pregnancy, Current Hepatitis Reports, 2010, 9, 4, 197

    CrossRef

  15. 15
    FRED Y. AOKI, FREDERICK G. HAYDEN, RAPHAEL DOLIN, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  16. 16
    Haruhiko Kobashi, Kouichi Takaguchi, Hiroshi Ikeda, Osamu Yokosuka, Mitsuhiko Moriyama, Fumio Imazeki, Masayoshi Kage, Taku Seriu, Masao Omata, Kousaku Sakaguchi, Yasushi Shiratori, Efficacy and safety of entecavir in nucleoside-naive, chronic hepatitis B patients: Phase II clinical study in Japan, Journal of Gastroenterology and Hepatology, 2009, 24, 2
  17. 17
    Sharon R. Lewin, Ruy M. Ribeiro, Anchalee Avihingsanon, Scott Bowden, Gail Matthews, Pip Marks, Stephen A. Locarnini, Kiat Ruxrungtham, Alan S. Perelson, Gregory J. Dore, Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1–hepatitis B virus coinfected individuals: Similar effectiveness of lamivudine, tenofovir, or combination therapy, Hepatology, 2009, 49, 4
  18. 18
    Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Hiromi Yatsuji, Hitomi Sezaki, Yasuji Arase, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki, Hiromitsu Kumada, Changes in viral loads of lamivudine-resistant mutants during entecavir therapy, Hepatology Research, 2008, 38, 2
  19. 19
    José Luis Calleja, Beatriz Peñas, Entecavir, Enfermedades Infecciosas y Microbiología Clínica, 2008, 26, 39

    CrossRef

  20. 20
    Pin-Nan Cheng, Ting-Tsung Chang, Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients, Expert Review of Anti-infective Therapy, 2008, 6, 5, 569

    CrossRef

  21. 21
    Cihan Yurdaydin, Entecavir: a step forward in combating hepatitis B disease, Expert Opinion on Pharmacotherapy, 2008, 9, 17, 3095

    CrossRef

  22. 22
    Nancy Leung, Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues, Hepatology International, 2008, 2, 2, 163

    CrossRef

  23. 23
    Ramón Planas, Rosa M. Morillas, Tratamiento de la infección por el virus de la hepatitis B. Estado actual y perspectivas, Gastroenterología y Hepatología, 2008, 31, 6, 349

    CrossRef

  24. 24
    Tetsuya Ishikawa, Shinichi Kakumu, Combination therapy with lamivudine and HB vaccine on chronic hepatitis B, Hepatology Research, 2007, 37,
  25. 25
    Margarita Pardo, Javier Bartolomé, Vicente Carreño, Current Therapy of Chronic Hepatitis B, Archives of Medical Research, 2007, 38, 6, 661

    CrossRef

  26. 26
    José Luis Calleja, Beatriz Peñas, Entecavir: nueva esperanza para el tratamiento de la hepatitis B crónica, Gastroenterología y Hepatología, 2007, 30, 5, 285

    CrossRef

  27. 27
    Robert G. Gish, Stephen Locarnini, Genotyping and Genomic Sequencing in Clinical Practice, Clinics in Liver Disease, 2007, 11, 4, 761

    CrossRef

  28. 28
    Robert G. Gish, Improving outcomes for patients with chronic hepatitis B, Hepatology Research, 2007, 37,
  29. 29
    Kwan Sik Lee, Dong Joon Kim, Management of Chronic Hepatitis B, The Korean Journal of Hepatology, 2007, 13, 4, 447

    CrossRef

  30. 30
    Emmet B. Keeffe, Patrick Marcellin, New and Emerging Treatment of Chronic Hepatitis B, Clinical Gastroenterology and Hepatology, 2007, 5, 3, 285

    CrossRef

  31. 31
    Fumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, Hiromi Yatsuji, Hitomi Sezaki, Yasuji Arase, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki, Hiromitsu Kumada, Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H, Journal of Clinical Virology, 2007, 39, 2, 149

    CrossRef

  32. 32
    Victor Pérez, Viral Hepatitis: Historical Perspectives from the 20th to the 21st Century, Archives of Medical Research, 2007, 38, 6, 593

    CrossRef

  33. 33
    Stephen Locarnini, William S. Mason, Cellular and virological mechanisms of HBV drug resistance, Journal of Hepatology, 2006, 44, 2, 422

    CrossRef

  34. 34
    Dean M Robinson, Lesley J Scott, Greg L Plosker, Entecavir, Drugs, 2006, 66, 12, 1605

    CrossRef

  35. 35
    S. James Matthews, Entecavir for the treatment of chronic hepatitis B virus infection, Clinical Therapeutics, 2006, 28, 2, 184

    CrossRef

  36. 36
    Keri A. Sims, Abigail M. Woodland, Entecavir: A New Nucleoside Analog for the Treatment of Chronic Hepatitis B Infection, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006, 26, 12
  37. 37
    Fabien Zoulim, Entecavir: A new treatment option for chronic hepatitis B, Journal of Clinical Virology, 2006, 36, 1, 8

    CrossRef

  38. 38
    Homayon Sidiq, Victor Ankoma-Sey, HIV-Related Liver Disease: Infections Versus Drugs, Gastroenterology Clinics of North America, 2006, 35, 2, 487

    CrossRef

  39. 39
    Tarik Asselah, Corinne Castelnau, Patrick Marcellin, Traitement de l’hépatite chronique B, La Presse Médicale, 2006, 35, 2, 327

    CrossRef

  40. 40
    Ting–Tsung Chang, Robert G. Gish, Stephanos J. Hadziyannis, Janusz Cianciara, Mario Rizzetto, Eugene R. Schiff, Giuseppe Pastore, Bruce R. Bacon, Thierry Poynard, Shobha Joshi, Kenneth S. Klesczewski, Alexandra Thiry, Ronald E. Rose, Richard J. Colonno, Robert G. Hindes, A Dose-Ranging Study of the Efficacy and Tolerability of Entecavir in Lamivudine-Refractory Chronic Hepatitis B Patients, Gastroenterology, 2005, 129, 4, 1198

    CrossRef

  41. 41
    Anastasia Rivkin, A review of entecavir in the treatment of chronic hepatitis B infection, Current Medical Research and Opinion, 2005, 21, 11, 1845

    CrossRef

  42. 42
    MG Brook, R Gilson, E Wilkins, BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis B virus infection (2005), HIV Medicine, 2005, 6, S2
  43. 43
    Yves Benhamou, HIV-1/hepatitis B coinfection, Expert Review of Anti-infective Therapy, 2005, 3, 2, 229

    CrossRef

  44. 44
    Marie-Noëlle Brunelle, Anne-Carole Jacquard, Christian Pichoud, David Durantel, Sandra Carrouée-Durantel, Jean-Pierre Villeneuve, Christian Trépo, Fabien Zoulim, Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir, Hepatology, 2005, 41, 6
  45. 45
    Marc D. Ogan, David J. Kucera, Yadagiri R. Pendri, J. Kent Rinehart, Synthesis of [14C]-radiolabelled entecavir, Journal of Labelled Compounds and Radiopharmaceuticals, 2005, 48, 9
  46. 46
    Tarik Asselah, Marie-Pierre Ripault, Corinne Castelnau, Nathalie Giuily, Nathalie Boyer, Patrick Marcellin, The current status of antiviral therapy of chronic hepatitis B, Journal of Clinical Virology, 2005, 34, S115

    CrossRef

  47. 47
    P. Marcellin, T. Asselah, N. Boyer, Treatment of chronic hepatitis B, Journal of Viral Hepatitis, 2005, 12, 4
  48. 48
    MICHAEL R. CHARLTON, K. V. NARAYANAN MENON, Transplantation of the Liver, 2005,

    CrossRef

  49. 49
    Patrick Marcellin, Herve Mommeja-Marin, Stephen L. Sacks, George K. K. Lau, Daniel Sereni, Jean-Pierre Bronowicki, Brian Conway, Christian Trepo, M. Robert Blum, Byung Chul Yoo, Elsa Mondou, Jeff Sorbel, Andrea Snow, Franck Rousseau, Hyo-Suk Lee, A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B, Hepatology, 2004, 40, 1
  50. 50
    D. Lavanchy, Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures, Journal of Viral Hepatitis, 2004, 11, 2
  51. 51
    M. S. Dai, P. F. Wu, R. Y. Shyu, J. J. Lu, T. Y. Chao, Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration, Liver International, 2004, 24, 6
  52. 52
    F.Fred Poordad, Liver transplant and recurrent disease, Clinics in Liver Disease, 2004, 8, 2, 461

    CrossRef

  53. 53
    Marc G. Ghany, Edward C. Doo, Management of chronic hepatitis B, Gastroenterology Clinics of North America, 2004, 33, 3, 563

    CrossRef

  54. 54
    Susanne Beckebaum, Vito R. Cicinnati, Guido Gerken, Christoph Erich Broelsch, Management of chronic hepatitis B in the liver transplant setting, Transplantation Reviews, 2004, 18, 4, 171

    CrossRef

  55. 55
    Chee-kin Hui, Hai-ying Zhang, George K.K. Lau, Management of chronic hepatitis B in treatment-experienced patients, Gastroenterology Clinics of North America, 2004, 33, 3, 601

    CrossRef

  56. 56
    H. M. Younger, A. J. Bathgate, P. C. Hayes, Review article: nucleoside analogues for the treatment of chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2004, 20, 11-12
  57. 57
    Danny K.W. Soon, Stephen L. Lowe, Choo Hua Teng, Kwee Poo Yeo, James McGill, Stephen D. Wise, Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection, Journal of Hepatology, 2004, 41, 5, 852

    CrossRef

  58. 58
    Tarik Asselah, Corinne Castelnau, Nathalie Boyer, Marie-Pierre Ripault, Patrick Marcellin, Traitement de l’hépatite chronique B, Gastroentérologie Clinique et Biologique, 2004, 28, 12, 1215

    CrossRef

  59. 59
    L. D. Saravolatz, D. M. Asmuth, H. H. Nguyen, G. P. Melcher, S. H. Cohen, R. B. Pollard, Treatments for Hepatitis B, Clinical Infectious Diseases, 2004, 39, 9, 1353

    CrossRef

  60. 60
    Anneke K Raney, Robert K Hamatake, Zhi Hong, Agents in clinical development for the treatment of chronic hepatitis B, Expert Opinion on Investigational Drugs, 2003, 12, 8, 1281

    CrossRef

  61. 61
    MG Brook, R Gilson, EL Wilkins, BHIVA Guidelines: coinfection with HIV and Chronic hepatitis B virus, HIV Medicine, 2003, 4, S1
  62. 62
    Justin G Julander, Richard J Colonno, Robert W Sidwell, John D Morrey, Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus, Antiviral Research, 2003, 59, 3, 155

    CrossRef

  63. 63
    Susanne Beckebaum, Massimo Malagó, Olaf Dirsch, Vito R Cicinnati, Martin Trippler, Pietro Lampertico, Nicole Lama, Ulrich Treichel, Guido Gerken, Christoph E Broelsch, Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation, Clinical Transplantation, 2003, 17, 6
  64. 64
    Maria Buti, Rafael Esteban, Entecavir, FTC, L-FMAU, LdT and others, Journal of Hepatology, 2003, 39, 139

    CrossRef

  65. 65
    P Honkoop, RA de Man, Entecavir: a potent new antiviral drug for hepatitis B, Expert Opinion on Investigational Drugs, 2003, 12, 4, 683

    CrossRef

  66. 66
    PD Griffiths, The end of the needle is in sight, Reviews in Medical Virology, 2003, 13, 6
  67. 67
    M. Nunez, M. Puoti, N. Camino, V. Soriano, Treatment of Chronic Hepatitis B in the Human Immunodeficiency Virus-Infected Patient: Present and Future, Clinical Infectious Diseases, 2003, 37, 12, 1678

    CrossRef

  68. 68
    HUBERT E BLUM, DARIUS MORADPOUR, Antiviral treatment of patients with HBV-related cirrhosis, Journal of Gastroenterology and Hepatology, 2002, 17,
  69. 69
    Tim Shaw, Scott Bowden, Stephen Locarnini, Chemotherapy for hepatitis B: New treatment options necessitate reappraisal of traditional endpoints, Gastroenterology, 2002, 123, 6, 2135

    CrossRef

  70. 70
    Anastasia Rivkina, Sergey Rybalov, Chronic Hepatitis B: Current and Future Treatment Options, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002, 22, 6
  71. 71
    Current Awareness, Pharmacoepidemiology and Drug Safety, 2002, 11, 1
  72. 72
    Ching–Lung Lai, Mohamed Rosmawati, Judy Lao, Hans Van Vlierberghe, Frank H. Anderson, Neal Thomas, Deborah Dehertogh, Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection, Gastroenterology, 2002, 123, 6, 1831

    CrossRef

  73. 73
    Robert P. Perrillo, How will we use the new antiviral agents for hepatitis B?, Current Gastroenterology Reports, 2002, 4, 1, 63

    CrossRef

  74. 74
    Lori L Siatkosky, Kenneth M Shermock, Zobair M Younossi, Investigational pharmacologic treatment for liver disease, Expert Opinion on Investigational Drugs, 2002, 11, 9, 1281

    CrossRef

  75. 75
    CHUTIMA PRAMOOLSINSUP, Management of viral hepatitis B, Journal of Gastroenterology and Hepatology, 2002, 17,
  76. 76
    Hakan Bozkaya, Cihan Yurdaydin, Abdullah Mithat Bozdayi, Ozlem Erkan, Selim Karayalcin, Ozden Uzunalimoglu, Oral Ganciclovir for Treatment of Lamivudine-Resistant Hepatitis B Virus Infection: A Pilot Study, Clinical Infectious Diseases, 2002, 35, 8, 960

    CrossRef

  77. 77
    Sandro Vento, Francesca Cainelli, Maria Serena Longhi, Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue, The Lancet Oncology, 2002, 3, 6, 333

    CrossRef

  78. 78
    Jose Franco, Kia Saeian, Role of Antiviral Therapy in the Prevention of Hepatocellular Carcinoma, Journal of Vascular and Interventional Radiology, 2002, 13, 9, S191

    CrossRef

  79. 79
    P. Marcellin, C. Castelnau, N. Boyer, Traitement de l'hépatite B, La Revue de Médecine Interne, 2002, 23, 535s

    CrossRef

  80. 80
    Leonieke M.M Wolters, Bettina E Hansen, Hubert G.M Niesters, Deborah DeHertogh, Robert A de Man, Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B, Journal of Hepatology, 2002, 37, 1, 137

    CrossRef

  81. 81
    Ricardo Marrero, Eugene Schiff, Viral hepatitis, Current Opinion in Gastroenterology, 2002, 18, 3, 330

    CrossRef

  82. 82
    Nicholas A Meanwell, John F Kadow, Paul M Scola, Annual Reports in Medicinal Chemistry Volume 37, 2002,

    CrossRef

  83. 83
    Man-Fung Yuen, Ching-Lung Lai, Treatment of chronic hepatitis B, The Lancet Infectious Diseases, 2001, 1, 4, 232

    CrossRef

  84. 84
    Richard Wilber, Bruce Kreter, Marc Bifano, Stephanie Danetz, Lois Lehman-McKeeman, Daniel J. Tenney, Nicholas Meanwell, Robert Zahler, Helena Brett-Smith, Discovery and Development of Entecavir,
  85. 85
    Jian Hong Zhong, Le Qun Li, Liu Cheng Wu, Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma, The Cochrane Library,
  86. 86
    Jian Hong Zhong, Le Qun Li, Liu Cheng Wu, Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma, The Cochrane Library,
  87. 87
    Jianing Wang, Ravindra K. Rawal, Chung K. Chu, Recent Advances in Carbocyclic Nucleosides: Synthesis and Biological Activity,